The launch of BIRSA 101 marks a major breakthrough in CRISPR gene-editing technology, positioning India to deliver affordable ...

The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great ...

Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Ryan Dodson, 18, was diagnosed with sickle cell disease ...

A view of paintings related to sickle cell on a table as Dominique Goodson, who has sickle cell and advocates for awareness about the disease, takes a phone call in her room at her home in the ...

In a step towards eliminating sickle cell disease, which disproportionately affects India’s tribal population, the government ...

Fifteen-year-old Jayden Wilsey of Falmouth is the first person at Boston Children's Hospital to receive human gene therapy for sickle cell disease, following approval of the therapy in 2024 by the U.S ...

UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 ...

Exagamglogene autotemcel (exa-cel) significantly improved HRQOL in severe SCD patients, eliminating severe VOCs and hospitalizations in most cases. The CLIMB SCD-121 trial showed sustained ...

Mixed headlines have plagued the cell and gene therapy space of late. We believe that a renewed case of optimism is not only ...

India has launched BIRSA 101, the nation’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease, marking a ...